BAYESIAN APPROACH FOR ELEVATE IPF: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE EFFICACY, SAFETY, AND DOSE RESPONSE OF DEUPIRFENIDONE (LYT-100) IN IPF

deupirfenidone (LYT-100) - PureTech

nerandomilast (BI 1015550) - Boehringer Ingelheim

nintedanib - Generic mfg.

admilparant (BMS-986278) - BMS

YANQIONG ZHANG; CAMILLA GRAHAM; DAVID GOLOD; SARAH SANTIPADRI; THOMAS JENSEN; BARBARA WENDELBERGER; JULIE KROP; CAROL A SATLER

Sep 11, 2024